ArticleMedComm2026

Clinical Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy for Triple-Negative Breast Cancer and Tumor Immune Microenvironment Analysis: A Prospective-Retrospective Cohort Study.

Yongsheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.